Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedApr 07, 2026
DataAggregated Company Financials
Companies23
  • 7D3.1%
  • 3M-20.6%
  • 1Y-10.0%
  • YTD-20.5%

Over the last 7 days, the Pharma industry has risen 3.1%, driven by gains from Camurus of 3.6%. Meanwhile, Flerie actually underperformed within the industry, shrinking 18% in the last week. In the past year, the industry is down 10.0%. Looking forward, earnings are forecast to grow by 35% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 07 Apr 2026SEK 41.5bSEK 5.3b-SEK 1,376,536,671.0055.9x-30.1x7.9x
Thu, 05 Mar 2026SEK 41.4bSEK 5.3b-SEK 1,379,477,946.0054.5x-30x7.9x
Sat, 31 Jan 2026SEK 50.5bSEK 5.3b-SEK 1,000,645,157.0056.3x-50.5x9.5x
Mon, 29 Dec 2025SEK 49.1bSEK 5.3b-SEK 531,735,157.0071x-92.3x9.3x
Wed, 26 Nov 2025SEK 49.6bSEK 5.3b-SEK 519,510,177.0070.7x-95.5x9.4x
Fri, 24 Oct 2025SEK 49.7bSEK 5.1b-SEK 148,483,865.0078.5x-334.6x9.7x
Sun, 21 Sep 2025SEK 56.4bSEK 5.1b-SEK 405,183,865.0072.3x-139.2x11.1x
Tue, 19 Aug 2025SEK 54.0bSEK 5.1b-SEK 318,636,364.0072.3x-169.4x10.7x
Thu, 17 Jul 2025SEK 57.1bSEK 4.8b-SEK 523,125,364.0078.5x-109.1x11.9x
Sat, 14 Jun 2025SEK 51.4bSEK 4.8b-SEK 574,323,223.7969.3x-89.4x10.6x
Mon, 12 May 2025SEK 53.4bSEK 4.7b-SEK 725,026,734.2281x-73.7x11.5x
Wed, 09 Apr 2025SEK 45.7bSEK 4.7b-SEK 809,513,213.3565.7x-56.4x9.7x
Fri, 07 Mar 2025SEK 51.2bSEK 4.7b-SEK 809,238,078.5475.2x-63.3x10.9x
Sun, 02 Feb 2025SEK 52.2bSEK 4.4b-SEK 810,084,336.88131.7x-64.5x11.8x
Tue, 31 Dec 2024SEK 49.9bSEK 4.4b-SEK 615,716,077.21123.4x-81.1x11.2x
Thu, 28 Nov 2024SEK 49.5bSEK 4.4b-SEK 619,603,873.63122.3x-79.8x11.1x
Sat, 26 Oct 2024SEK 52.5bSEK 4.3b-SEK 684,631,311.23138.5x-76.7x12.1x
Mon, 23 Sep 2024SEK 66.9bSEK 5.9b-SEK 1,170,009,772.77176.8x-57.2x11.4x
Wed, 21 Aug 2024SEK 69.0bSEK 5.9b-SEK 932,298,387.1089.8x-74x11.7x
Fri, 19 Jul 2024SEK 67.4bSEK 5.5b-SEK 989,165,040.87116.2x-68.2x12.2x
Sun, 16 Jun 2024SEK 62.1bSEK 6.4b-SEK 862,373,016.3670.2x-72x9.8x
Tue, 14 May 2024SEK 53.3bSEK 6.4b-SEK 803,405,779.9971.6x-66.4x8.4x
Thu, 11 Apr 2024SEK 51.6bSEK 6.2b-SEK 1,038,245,918.1879.2x-49.7x8.3x
Sat, 09 Mar 2024SEK 50.1bSEK 6.2b-SEK 1,038,035,434.2277.2x-48.3x8x
Mon, 05 Feb 2024SEK 68.3bSEK 9.5b-SEK 1,181,825,181.0064.2x-57.8x7.2x
Wed, 03 Jan 2024SEK 67.9bSEK 9.4b-SEK 1,184,276,916.0063.9x-57.3x7.2x
Fri, 01 Dec 2023SEK 61.8bSEK 9.5b-SEK 1,210,427,125.0055.8x-51.1x6.5x
Sun, 29 Oct 2023SEK 51.9bSEK 9.3b-SEK 1,115,122,341.0080x-46.6x5.6x
Tue, 26 Sep 2023SEK 51.7bSEK 9.2b-SEK 1,177,306,178.00139.1x-43.9x5.6x
Thu, 24 Aug 2023SEK 50.9bSEK 9.2b-SEK 1,164,852,805.0086.7x-43.7x5.5x
Sat, 22 Jul 2023SEK 51.1bSEK 8.8b-SEK 1,370,084,432.0076.5x-37.3x5.8x
Mon, 19 Jun 2023SEK 48.3bSEK 8.4b-SEK 1,692,983,342.0078.5x-28.5x5.8x
Wed, 17 May 2023SEK 49.0bSEK 8.4b-SEK 1,754,868,581.0088.8x-27.9x5.9x
Fri, 14 Apr 2023SEK 45.9bSEK 8.0b-SEK 1,794,974,246.0090.8x-25.6x5.7x
Price to Earnings Ratio

-25.6x


Total Market Cap: SEK 45.9bTotal Earnings: -SEK 1,794,974,246.00Total Revenue: SEK 8.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -73.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.0x is higher than the industry's current PS ratio of 7.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 13% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market2.65%
Healthcare3.47%
Pharma3.06%
Pharma3.06%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 483.603.6%
+SEK 991.8m		-9.9%PE39.3x
SECARE SwedencareSEK 25.204.3%
+SEK 167.8m		-29.6%PE72.6x
KLAR Klaria Pharma Holding AB (publ.)SEK 0.9513.3%
+SEK 27.5m		-16.9%PS26.1x
CESSA CessatechDKK 17.945.5%
+DKK 17.5m		97.1%PS58.3x
PILA Pila PharmaSEK 2.0917.8%
+SEK 14.4m		-36.4%PS84.5x

Latest News

KLAR
SEK 0.95
Klaria Pharma Holding AB (publ.)
7D
13.3%
1Y
-16.9%
MOB
SEK 10.50
Moberg Pharma
7D
1.7%
1Y
45.8%

MOB: Dual Terbinafine Sourcing Will Support Future Re Rating Potential

Analysts have reaffirmed their price target for Moberg Pharma at SEK 13.0 per share, citing unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Regulators have approved an additional supplier of terbinafine for MOB-015, Moberg Pharma's drug for nail fungus, after a process that started in April 2024 (Key Developments).
ORX
SEK 22.25
Orexo
7D
1.8%
1Y
58.9%
CAMX
SEK 483.60
Camurus
7D
3.6%
1Y
-9.9%

CAMX: FDA Review Of Resubmitted NDA Will Drive Future Upside

Analysts have trimmed their 12 month price target for Camurus from SEK 660 to SEK 610, citing updated assumptions that include revised revenue growth, profit margin and future P/E expectations. What's in the News Camurus issued earnings guidance for 2026, with expected revenues of SEK 2.6b to SEK 2.9b and an operating result of SEK 0.9b to SEK 1.2b, framed against internal 2025 expectations (Key Developments).
IBT B
SEK 49.40
Infant Bacterial Therapeutics
7D
-1.8%
1Y
-0.8%
SECARE
SEK 25.20
Swedencare
7D
4.3%
1Y
-29.6%
ERMA
SEK 0.42
Enorama Pharma
7D
20.3%
1Y
-81.7%
PILA
SEK 2.09
Pila Pharma
7D
17.8%
1Y
-36.4%
GABA
SEK 0.046
Gabather
7D
-4.6%
1Y
21.3%
FLERIE
SEK 29.70
Flerie
7D
-18.4%
1Y
-27.5%
IRLAB A
SEK 1.43
IRLAB Therapeutics
7D
-5.1%
1Y
-79.9%
CESSA
DKK 17.94
Cessatech
7D
5.5%
1Y
97.1%
ENZY
SEK 3.08
Enzymatica
7D
-3.1%
1Y
-16.1%
CINPHA
SEK 16.30
Cinclus Pharma Holding
7D
-3.4%
1Y
47.9%
DICOT
SEK 0.42
Dicot Pharma
7D
-2.2%
1Y
53.8%

Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Feb 03
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?
STABL
SEK 0.19
Stayble Therapeutics
7D
-13.2%
1Y
-57.1%